In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Actuate Therapeutics Inc (NASDAQ: ACTU) closed at $6.56 in the last session, down -0.76% from day before closing price of $6.61. In other words, the price has decreased by -$0.76 from its previous closing price. On the day, 57946.0 shares were traded. ACTU stock price reached its highest trading level at $6.72 during the session, while it also had its lowest trading level at $6.39.
Ratios:
We take a closer look at ACTU’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.74 and its Current Ratio is at 2.74. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In the most recent recommendation for this company, B. Riley Securities on August 26, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On April 22, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $21.
On March 17, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $20.H.C. Wainwright initiated its Buy rating on March 17, 2025, with a $20 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 11 ’25 when Kairos Venture Partners II, L. bought 280,000 shares for $7.60 per share.
Bios Equity COF, LP bought 71,428 shares of ACTU for $499,996 on Jun 27 ’25. The Director now owns 196,428 shares after completing the transaction at $7.00 per share. On Jun 27 ’25, another insider, Kreis Leslie W., who serves as the Director of the company, bought 71,428 shares for $7.00 each. As a result, the insider paid 499,996 and bolstered with 196,428 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACTU now has a Market Capitalization of 152476224 and an Enterprise Value of 135551472.
Stock Price History:
The Beta on a monthly basis for ACTU is -0.28, which has changed by -0.21309525 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, ACTU has reached a high of $11.99, while it has fallen to a 52-week low of $5.47. The 50-Day Moving Average of the stock is -3.92%, while the 200-Day Moving Average is calculated to be -13.91%.
Shares Statistics:
According to the various share statistics, ACTU traded on average about 72.40K shares per day over the past 3-months and 116650 shares per day over the past 10 days. A total of 23.24M shares are outstanding, with a floating share count of 9.57M. Insiders hold about 58.83% of the company’s shares, while institutions hold 9.94% stake in the company. Shares short for ACTU as of 1764288000 were 483575 with a Short Ratio of 6.04, compared to 1761868800 on 491311. Therefore, it implies a Short% of Shares Outstanding of 483575 and a Short% of Float of 4.97.
